Literature DB >> 17522392

Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) may reflect tissue RAGE expression in diabetes.

Sho-ichi Yamagishi, Tsutomu Imaizumi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17522392     DOI： 10.1161/ATVBAHA.107.139923

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN： 1079-5642            Impact factor:   8.311


× No keyword cloud information.
  11 in total

1.  Diabetes Mellitus and Blood-Brain Barrier Dysfunction: An Overview.

Authors:  Shikha Prasad; Ravi K Sajja; Pooja Naik; Luca Cucullo
Journal:  J Pharmacovigil       Date:  2014-06

Review 2.  Contribution of the toxic advanced glycation end-products-receptor axis in nonalcoholic steatohepatitis-related hepatocellular carcinoma.

Authors:  Jun-Ichi Takino; Kentaro Nagamine; Takamitsu Hori; Akiko Sakasai-Sakai; Masayoshi Takeuchi
Journal:  World J Hepatol       Date:  2015-10-18

Review 3.  Involvement of the TAGE-RAGE system in non-alcoholic steatohepatitis: Novel treatment strategies.

Authors:  Masayoshi Takeuchi; Jun-Ichi Takino; Akiko Sakasai-Sakai; Takanobu Takata; Tadashi Ueda; Mikihiro Tsutsumi; Hideyuki Hyogo; Sho-Ichi Yamagishi
Journal:  World J Hepatol       Date:  2014-12-27

4.  Involvement of TAGE-RAGE System in the Pathogenesis of Diabetic Retinopathy.

Authors:  Masayoshi Takeuchi; Jun-Ichi Takino; Sho-Ichi Yamagishi
Journal:  J Ophthalmol       Date:  2010-06-22       Impact factor: 1.909

5.  The effects of n-3 long-chain polyunsaturated fatty acid supplementation on AGEs and sRAGE in type 2 diabetes mellitus.

Authors:  Asuman Kurt; Gülnur Andican; Zeynep Oşar Siva; Ahat Andican; Gülden Burcak
Journal:  J Physiol Biochem       Date:  2016-07-22       Impact factor: 4.158

Review 6.  Regulation of RAGE for attenuating progression of diabetic vascular complications.

Authors:  Myat Thu Thu Win; Yasuhiko Yamamoto; Seiichi Munesue; Hidehito Saito; Dong Han; So Motoyoshi; Tarek Kamal; Takuro Ohara; Takuo Watanabe; Hiroshi Yamamoto
Journal:  Exp Diabetes Res       Date:  2011-10-29

7.  sRAGE in diabetic and non-diabetic critically ill patients: effects of intensive insulin therapy.

Authors:  Yaseen M Arabi; Mohammed Dehbi; Asgar H Rishu; Engin Baturcam; Salim H Kahoul; Riette J Brits; Brintha Naidu; Abderrezak Bouchama
Journal:  Crit Care       Date:  2011-08-26       Impact factor: 9.097

8.  Receptor for advanced glycation end-products and ARDS prediction: a multicentre observational study.

Authors:  Matthieu Jabaudon; Pauline Berthelin; Thibaut Pranal; Laurence Roszyk; Thomas Godet; Jean-Sébastien Faure; Russell Chabanne; Nathanael Eisenmann; Alexandre Lautrette; Corinne Belville; Raiko Blondonnet; Sophie Cayot; Thierry Gillart; Julien Pascal; Yvan Skrzypczak; Bertrand Souweine; Loic Blanchon; Vincent Sapin; Bruno Pereira; Jean-Michel Constantin
Journal:  Sci Rep       Date:  2018-02-08       Impact factor: 4.379

9.  Polymorphisms in the receptor for advanced glycation end-products (RAGE) gene and circulating RAGE levels as a susceptibility factor for non-alcoholic steatohepatitis (NASH).

Authors:  Rohini Mehta; Gladys Shaw; Peter Masschelin; Sean Felix; Munkzhul Otgonsuren; Ancha Baranova; Zachary Goodman; Zobair Younossi
Journal:  PLoS One       Date:  2018-06-21       Impact factor: 3.240

10.  Levels of Soluble Receptor for Advanced Glycation End Products in Acute Ischemic Stroke without a Source of Cardioembolism.

Authors:  Hyun-Young Park; Kyeong Ho Yun; Do-Sim Park
Journal:  J Clin Neurol       Date:  2009-09-30       Impact factor: 3.077
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.